Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.

Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...

Supraventricular tachycardia (SVT) is a very rapid heartbeat (usually between 151 and 250 beats per minute, or BPM) and can cause a number of serious health issues. It’s seen in just over 2 out of ...

The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...

Atrial tachycardia is an unusually fast heartbeat that originates in the atria, or upper chambers, of the heart. It is a type of supraventricular tachycardia (SVT). This means it begins above the ...

Please provide your email address to receive an email when new articles are posted on . Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ...